Fasano Genevieve A, Bayard Solange, Bea Vivian J
Department of Surgery, New York Presbyterian - Weill Cornell Medicine, New York, NY USA.
Department of Surgery, New York Presbyterian Brooklyn Methodist Hospital, 506 6th Street, Brooklyn, New York, NY 11215 USA.
Curr Breast Cancer Rep. 2022;14(4):192-198. doi: 10.1007/s12609-022-00458-y. Epub 2022 Aug 30.
The COVID-19 pandemic has placed unprecedented challenges on breast cancer patients and health care providers. The impact of the pandemic on preexisting breast cancer disparities remains unknown but is projected to have adverse outcomes.
Early work has demonstrated that pandemic-related temporary suspensions in breast cancer screening, interruption of clinical trials, and treatment delays have an adverse impact on breast cancer patient outcomes and may worsen disparities.
In this review, we highlight existing knowledge regarding breast cancer disparities and the impact of the COVID-19 pandemic. Strategies for mitigating disparities moving forward include targeted research evaluating race-specific outcomes, targeted education for providers regarding breast health disparities, improved access to telehealth, maintenance of patient navigation programs, and patient education regarding the safety and necessity of enrollment in clinical trials.
新冠疫情给乳腺癌患者和医疗服务提供者带来了前所未有的挑战。疫情对已存在的乳腺癌差异的影响尚不清楚，但预计会产生不良后果。
早期研究表明，与疫情相关的乳腺癌筛查临时暂停、临床试验中断和治疗延迟对乳腺癌患者的预后有不利影响，可能会加剧差异。
在本综述中，我们强调了关于乳腺癌差异以及新冠疫情影响的现有知识。未来减轻差异的策略包括评估种族特异性结果的针对性研究、针对医疗服务提供者开展关于乳腺健康差异的针对性教育、改善远程医疗的可及性、维持患者导航项目，以及对患者进行关于参与临床试验的安全性和必要性的教育。
